(Q61924360)
Statements
A Phase 2 Study of Pemetrexed Versus Pemetrexed Plus Erlotinib in Second-Line Treatment in Patients With Nonsquamous NSCLC (English)
0 references
March 2007
0 references
July 2010
0 references
204
0 references
18 year
0 references